WADA’s Executive Committee will meet on Saturday September 16 in Montreal for the second time this year.
At this meeting, Executive Committee members will approve the 2007 List of Prohibited Substances and Methods, which will be published by October 1, 2006, and will go into effect on January 1, 2007.
The Executive Committee will also approve new scientific research projects to be funded by WADA, and discuss the status of artificially-induced hypoxic conditions following a consultation process which provided the Agency’s stakeholders with an opportunity to express their opinion on this matter.
Among other topics to be addressed by WADA Executive Committee members are the review of the comments received from stakeholders as part of the first of the three consultation phases of the World Anti-Doping Code review process, as well as current issues in relation to recent doping cases and investigations.
In addition, WADA’s Executive Committee members will be updated on the Agency’s activities in the areas of research, testing, education, anti-doping development, Independent Observers, monitoring of stakeholders’ compliance with the World Anti-Doping Code, and regional offices.
Click here for a recording of WADA’s president press conference on September 14.